Marc Bourliere

8PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis.

|Apr 27, 2026
Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France.

|Mar 11, 2026
Steatosis severity and metabolic fingerprints after HCV eradication: toward an individualised approach to HCC surveillance after HCV cure.

Lucia Parlati, Marc Bourliere

|Feb 27, 2026
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.

Gia Landry, Mark Sulkowski, Jordan J Feld

|Nov 18, 2025
Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France.

Fabienne Marcellin, Vincent di Beo, Philippe Sogni

|Nov 06, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim

Pageof 2

Frequent Collaborators

2 joint publications

Rodolphe Anty

2 joint publications

Cécile Brouard

1 joint publications

Xavier Adhoute

1 joint publications

Guillaume Pénaranda